Heska Corporation Revenue per Employee (HSKA), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Heska Corporation  (NASDAQ: HSKA)
 

Heska's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Heska's Revenue per employee fell on a trailing twelve month basis to $ 417,849, but the productivity of Heska's employees remained above the company average.
Within the Healthcare sector Employees of 131 other companies have achieved higher revenue per employee. While Heska's total ranking has deteriorated compared to the previous quarter from 1093 to 1175. Heska has 610 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

HSKA Revenue per Employee (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter
Y / Y Revenue Change -3.73 % -2.54 % 2.08 % -0.39 % 7.1 %
Sales per Employee (TTM) $ 417,849 421,815 424,651 422,598 423,010
HSKA's Total Ranking # 1175 # 1093 # 0 # 0 # 0
Seq. Revenue Change -5.96 % 7.88 % -4.92 % -0.19 % -4.8 %

HSKA Company Profile >> Back to HSKA Efficiency Comparisons >> Compare HSKA Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 25
Healthcare Sector # 132
Overall Market # 1175

Revenue per Employee Statistics
High Average Low
$ 487,946 $ 286,579 $ 156,472
(Sep 30 2021)   (June 30. 2014)



Financial Statements
Heska's Revenue MRQ $ 62 Millions Visit HSKA's Income Statement
Heska's Revenues TTM $ 255 Millions Visit HSKA's aggregate revenue growth
What are HSKA's Sales? Visit HSKA's Sales by Segment




Other Ratios
Heska's Income per Employee
Employees in In Vitro & In Vivo Diagnostic Substances
In Vitro & In Vivo Diagnostic Substances Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
HSKA's Revenue per Employee versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for HSKA's Competitors
Revenue per Employee for HSKA's Suppliers
Revenue per Employee for HSKA's Customers

You may also want to know
HSKA's Sales Growth Rates HSKA's Pe Price to earnings ratio HSKA's Receivables Turnover Ratio HSKA's Stock Quote
HSKA's Net Income Growth Rates HSKA's Ps Price to Sales ratio HSKA's Sales per Employee HSKA's Asset Turnover Ratio
HSKA's Net Margin HSKA's Pb Price to Book ratio HSKA's Financial Strength Ratios HSKA's Dividend Payout Ratio
Date modified: 2026-08-29T17:28:21+00:00




Companies with similar Revenue per Employee for 12 months ending Mar 31 2023, within Healthcare Sector Revenue per Employee Revenue 12 months ending Mar 31 2023Number of Employees Mar 31 2023
Luna Innovations Inc  700,381.25 $ 112.061  Million 160 
Johnson and Johnson  683,686.08 $ 96,263.000  Million 140,800 
Agile Therapeutics Inc  680,842.11 $ 12.936  Million 19 
Enanta Pharmaceuticals Inc  676,466.67 $ 81.176  Million 120 
Biomarin Pharmaceutical Inc  674,664.70 $ 2,173.095  Million 3,221 
Phenomex Inc   674,605.26 $ 76.905  Million 114 
Novan Inc   673,513.51 $ 24.920  Million 37 
Caremax Inc   667,195.00 $ 667.195  Million 1,000 
Biocryst Pharmaceuticals Inc   665,935.63 $ 289.682  Million 435 
Sigilon Therapeutics Inc   665,318.18 $ 14.637  Million 22 
Emmaus Life Sciences Inc   663,909.09 $ 21.909  Million 33 
Cardiff Lexington Corporation  662,115.39 $ 11.918  Million 18 
Amicus Therapeutics inc   659,076.32 $ 336.788  Million 511 
Dyadic International Inc   651,985.60 $ 3.260  Million 5 
Acadia Pharmaceuticals Inc   651,916.04 $ 520.229  Million 798 
Karyopharm Therapeutics Inc   649,570.18 $ 148.102  Million 228 
Ati Physical Therapy Inc   648,781.00 $ 648.781  Million 1,000 
Kiniksa Pharmaceuticals International Plc  645,726.78 $ 236.336  Million 366 
Evofem Biosciences Inc   634,310.34 $ 18.395  Million 29 
Sensus Healthcare Inc   626,800.00 $ 37.608  Million 60 
Neptune Wellness Solutions Inc   619,003.98 $ 52.615  Million 85 
2seventy Bio Inc   617,267.33 $ 124.688  Million 202 
Reshape Lifesciences Inc  615,944.44 $ 11.087  Million 18 
Skinhealth Systems Inc   614,582.38 $ 376.739  Million 613 
Organon and Co   614,500.00 $ 6,145.000  Million 10,000 
Assure Holdings Corp   614,187.50 $ 9.827  Million 16 
Embecta Corp   604,594.59 $ 1,118.500  Million 1,850 
Healthlynked Corp  600,648.40 $ 6.006  Million 10 
Iridex Corp  600,645.16 $ 55.860  Million 93 
Takeda Pharmaceutical Company Limited  593,666.58 $ 27,902.329  Million 47,000 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.